Rip Road

Rip Road specializes in developing and managing companion applications for biologic medications and their delivery devices, operating within the digital health and Software as a Medical Device (SaMD) market. The company serves pharmaceutical and medical device clients, providing them with a configurable platform to build and launch regulatory-compliant SaMD applications. This business model centers on licensing its platform, enabling clients to create customized apps that enhance patient engagement and adherence to complex therapies.

The company's history is rooted in mobile health, founded by individuals with a background as SMS and mobile data pioneers at AT&T Wireless. This team leveraged their expertise in consumer mobile usage to build an engaging patient tracking platform over the last decade. Their journey began in public health, creating some of the first SMS-based programs for organizations like the CDC and the Kaiser Family Foundation to promote testing for HIV and STDs. Over the years, Rip Road partnered with prominent healthcare institutions such as Mass General Hospital and Mt. Sinai Hospital to develop digital health solutions for a wide array of conditions, including diabetes, pain management, and ADHD. A significant milestone was achieved in March 2024, when the company received ISO 13485:2016 certification for its Quality Management System (QMS), affirming its commitment to regulatory standards for medical device software.

Rip Road's core product is the TrackRR platform, a fully managed SaaS solution that utilizes Patient Generated Health Data (PGHD) to keep patients engaged with their therapy. This platform integrates features for tracking symptoms and medication, providing motivation, offering feedback and insights through data visualizations, and facilitating communication between patients and their healthcare providers. The applications built on this platform help patients see the progression of their symptoms, understand if their medication is effective, and learn how adherence impacts their quality of life. By focusing on PGHD, Rip Road aims to empower patients to self-manage their conditions and have more informed discussions with their doctors, ultimately addressing the challenge of patient disengagement that can arise from brief or remote clinical visits.

Keywords: Software as a Medical Device, SaMD, patient engagement, medication adherence, biologics, companion applications, digital health, Patient Generated Health Data, PGHD, mobile health, TrackRR, therapy tracking, patient monitoring, digital therapeutics, pharmaceutical technology, connected devices, medical device software, patient support programs, healthcare applications, QMS, ISO 13485